ANI Pharmaceuticals, Inc. (ANIP)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 63.77 |
| Open | 63.86 |
| Bid | 61.34 x 200 |
| Ask | 61.69 x 100 |
| Day's range | 61.28 - 64.51 |
| 52-week range | 44.27 - 70.81 |
| Volume | |
| Avg. volume | 160,133 |
| Market cap | 1.288B |
| Beta (5Y monthly) | 0.81 |
| PE ratio (TTM) | 38.16 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Eli Lilly's (LLY) Efsitora Matches Daily Insulins in A1C Control
Eli Lilly's (LLY) two phase III studies on its once-weekly insulin, efsitora alfa, meet their primary endpoint of non-inferior reduction in blood sugar levels compared with daily basal insulins.
- Zacks
Amgen's (AMGN) Tarlatamab Receives FDA Approval for SCLC
Amgen's (AMGN) Imdelltra is the first DLL3-targeting BiTE therapy that activates the patient's own T cells to attack DLL3-expressing tumor cells.
- GuruFocus.com
Insider Selling: President & CEO Nikhil Lalwani Sells Shares of ANI Pharmaceuticals Inc (ANIP)
On May 14, 2024, Nikhil Lalwani, President & CEO of ANI Pharmaceuticals Inc (NASDAQ:ANIP), executed a sale of 16,669 shares of the company.
© 2024 Yahoo. All rights reserved.